Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.690
+0.010 (0.37%)
Aug 1, 2025, 4:00 PM - Market closed
Chimerix Market Cap
Kalaris Therapeutics has a market cap or net worth of $50.31 million as of August 1, 2025.
Market Cap
50.31M
Enterprise Value
-50.66M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $50.31M, a decrease of -76.55%. That is a compound annual growth rate of -98.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 50.31M | 0.37% |
Jul 31, 2025 | 50.12M | -0.37% |
Jul 30, 2025 | 50.31M | - |
Jul 29, 2025 | 50.31M | -8.03% |
Jul 28, 2025 | 54.70M | 5.98% |
Jul 25, 2025 | 51.62M | -2.82% |
Jul 24, 2025 | 53.11M | 2.53% |
Jul 23, 2025 | 51.81M | 7.78% |
Jul 22, 2025 | 48.07M | 6.20% |
Jul 21, 2025 | 45.26M | 1.26% |
Jul 18, 2025 | 44.70M | -1.24% |
Jul 17, 2025 | 45.26M | -1.63% |
Jul 16, 2025 | 46.01M | 2.50% |
Jul 15, 2025 | 44.89M | -8.05% |
Jul 14, 2025 | 48.81M | 7.41% |
Jul 11, 2025 | 45.45M | -2.80% |
Jul 10, 2025 | 46.76M | -1.96% |
Jul 9, 2025 | 47.69M | -1.16% |
Jul 8, 2025 | 48.25M | -1.15% |
Jul 7, 2025 | 48.81M | 4.40% |
Jul 3, 2025 | 46.76M | -2.34% |
Jul 2, 2025 | 47.88M | -0.78% |
Jul 1, 2025 | 48.25M | -3.37% |
Jun 30, 2025 | 49.94M | 1.91% |
Jun 27, 2025 | 49.00M | 2.34% |
Jun 26, 2025 | 47.88M | -1.54% |
Jun 25, 2025 | 48.63M | 4.42% |
Jun 24, 2025 | 46.57M | 5.51% |
Jun 23, 2025 | 44.14M | -1.67% |
Jun 20, 2025 | 44.89M | -6.61% |
Jun 18, 2025 | 48.07M | 0.39% |
Jun 17, 2025 | 47.88M | -4.12% |
Jun 16, 2025 | 49.94M | 1.14% |
Jun 13, 2025 | 49.37M | -4.35% |
Jun 12, 2025 | 51.62M | -4.83% |
Jun 11, 2025 | 54.24M | -5.84% |
Jun 10, 2025 | 57.60M | 0.65% |
Jun 9, 2025 | 57.23M | -7.27% |
Jun 6, 2025 | 61.72M | 6.11% |
Jun 5, 2025 | 58.16M | 0.65% |
Jun 4, 2025 | 57.79M | 0.32% |
Jun 3, 2025 | 57.60M | 2.67% |
Jun 2, 2025 | 56.11M | 3.45% |
May 30, 2025 | 54.24M | -2.03% |
May 29, 2025 | 55.36M | 2.07% |
May 28, 2025 | 54.24M | -0.34% |
May 27, 2025 | 54.42M | 4.30% |
May 23, 2025 | 52.18M | -1.41% |
May 22, 2025 | 52.93M | -5.03% |
May 21, 2025 | 55.73M | -10.51% |
May 20, 2025 | 62.28M | 2.46% |
May 19, 2025 | 60.78M | -6.61% |
May 16, 2025 | 65.08M | -1.69% |
May 15, 2025 | 66.21M | 4.73% |
May 14, 2025 | 63.21M | 4.00% |
May 13, 2025 | 60.78M | -3.85% |
May 12, 2025 | 63.21M | -2.87% |
May 9, 2025 | 65.08M | -9.61% |
May 8, 2025 | 72.00M | -10.47% |
May 7, 2025 | 80.42M | -10.23% |
May 6, 2025 | 89.58M | -11.46% |
May 5, 2025 | 101.18M | -7.20% |
May 2, 2025 | 109.04M | -0.34% |
May 1, 2025 | 109.41M | -6.70% |
Apr 30, 2025 | 117.26M | -9.13% |
Apr 29, 2025 | 129.05M | 2.83% |
Apr 28, 2025 | 125.49M | 0.15% |
Apr 25, 2025 | 125.31M | 2.76% |
Apr 24, 2025 | 121.94M | -6.99% |
Apr 23, 2025 | 131.10M | 3.70% |
Apr 22, 2025 | 126.43M | 2.27% |
Apr 21, 2025 | 123.62M | -5.44% |
Apr 17, 2025 | 130.73M | 4.33% |
Apr 16, 2025 | 125.31M | 3.72% |
Apr 15, 2025 | 120.82M | -6.10% |
Apr 14, 2025 | 128.67M | -4.84% |
Apr 11, 2025 | 135.22M | -1.09% |
Apr 10, 2025 | 136.71M | -5.19% |
Apr 9, 2025 | 144.20M | 9.05% |
Apr 8, 2025 | 132.23M | 7.12% |
Apr 7, 2025 | 123.44M | -6.78% |
Apr 4, 2025 | 132.41M | -4.32% |
Apr 3, 2025 | 138.40M | -8.30% |
Apr 2, 2025 | 150.93M | 0.88% |
Apr 1, 2025 | 149.62M | -0.37% |
Mar 31, 2025 | 150.18M | -6.63% |
Mar 28, 2025 | 160.84M | -4.55% |
Mar 27, 2025 | 168.51M | -2.17% |
Mar 26, 2025 | 172.25M | 4.42% |
Mar 25, 2025 | 164.96M | -16.00% |
Mar 24, 2025 | 196.38M | -4.55% |
Mar 21, 2025 | 205.73M | -3.51% |
Mar 20, 2025 | 213.21M | -0.61% |
Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 682.35B |
Johnson & Johnson | 402.82B |
AbbVie | 334.40B |
UnitedHealth Group | 241.34B |
AstraZeneca | 236.88B |
Novartis AG | 227.02B |
Abbott Laboratories | 223.66B |
Novo Nordisk | 221.96B |